TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
Status:
Recruiting
Trial end date:
2024-11-15
Target enrollment:
Participant gender:
Summary
REBOOT clinical trial will study whether long-term maintenance beta-blockers therapy results
in a clinical benefit after heart attack without reduced left ventricular function. Half of
the participants will be randomized to receive long-term beta-blocker therapy and the other
half to no beta-blocker therapy after hospital discharge. All patients will be followed up
for up to 3 years to determine the occurrence of adverse events (all cause mortality,
re-infarction, and heart failure admission).
Phase:
Phase 4
Details
Lead Sponsor:
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III